Pharmaceutical Economics and Policy PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Pharmaceutical Economics and Policy PDF full book. Access full book title Pharmaceutical Economics and Policy by Stuart O. Schweitzer. Download full books in PDF and EPUB format.
Author: Stuart O. Schweitzer
Publisher: Oxford University Press
ISBN: 9780195300956
Category : Business & Economics
Languages : en
Pages : 362
Get Book Here
Book Description
Publisher description
Author: Stuart O. Schweitzer
Publisher: Oxford University Press
ISBN: 9780195300956
Category : Business & Economics
Languages : en
Pages : 362
Get Book Here
Book Description
Publisher description
Author: Stuart O. Schweitzer
Publisher: Oxford University Press
ISBN: 0190623780
Category : Business & Economics
Languages : en
Pages : 433
Get Book Here
Book Description
The pharmaceutical industry -- The biotechnology industry -- Generics and biosimilars -- The global pharmaceutical industry -- The demand for pharmaceuticals -- The demand for pharmaceuticals in major international markets -- Pharmaceutical prices -- Economic evaluation of new drugs -- Pricing pharmaceuticals in a world environment -- Pharmaceutical marketing -- Patent protection -- Drug approval process in the United States -- Pharmaceutical regulation in the European Union -- Pharmaceuticals and public policy : a look ahead
Author: James W. Henderson
Publisher: Thomson South-Western
ISBN:
Category : Cost effectiveness
Languages : en
Pages : 508
Get Book Here
Book Description
This textbook examines the many issues surrounding the cost and structure of health care in the U.S, such as the market for health insurance, the market for health care practitioners, the aging population, the legal system, technology, and public policies. The second edition adds sections on quality differences between managed care and fee-for-service care, consolidation in the hospital industry, and the economics of state-level health insurance mandates. c. Book News Inc.
Author: Patricia M. Danzon
Publisher: Oxford University Press
ISBN: 0199909261
Category : Business & Economics
Languages : en
Pages : 618
Get Book Here
Book Description
The biopharmaceutical industry has been a major driver of technological change in health care, producing unprecedented benefits for patients, cost challenges for payers, and profits for shareholders. As consumers and companies benefit from access to new drugs, policymakers around the globe seek mechanisms to control prices and expenditures commensurate with value. More recently the 1990s productivity boom of new products has turned into a productivity bust, with fewer and more modest innovations, and flat or declining revenues for innovative firms as generics replace their former blockbuster products. This timely volume examines the economics of the biopharmaceutical industry, with eighteen chapters by leading academic health economists. Part one examines the economics of biopharmaceutical innovation including determinants of the costs and returns to new drug development; how capital markets finance R&D and how costs of financing the biopharmaceutical industry compare to financing costs for other industries; the effects of safety and efficacy regulation by the Food and Drug Administration (FDA) and of price and reimbursement regulation on incentives for innovation; and the role of patents and regulatory exclusivities. Part two examines the market for biopharmaceuticals with chapters on prices and reimbursement in the US, the EU, and other industrialized countries, and in developing countries. It looks at the optimal design of insurance for drugs and the effects of cost sharing on spending and on health outcomes; how to measure the value of pharmaceuticals using pharmacoeconomics, including theory, practical challenges, and policy issues; how to measure pharmaceutical price growth over time and recent evidence; empirical evidence on the value of pharmaceuticals in terms of health outcomes; promotion of pharmaceuticals to physicians and consumers; the economics of vaccines; and a review of the evidence on effects of mergers, acquisitions and alliances. Each chapter summarizes the latest insights from theory and recent empirical evidence, and outlines important unanswered questions and areas for future research. Based on solid economics, it is nevertheless written in terms accessible to the general reader. The book is thus recommended reading for academic economists and non-economists, and for those in industry and policy who wish to understand the economics of this fascinating industry.
Author: Jan Abel Olsen
Publisher: Oxford University Press
ISBN: 0198794835
Category : Business & Economics
Languages : en
Pages : 289
Get Book Here
Book Description
Examining the different structures and techniques involved in making decisions about who benefits from those health care resources available in a publicly funded system, this title provides a concise and compact introduction to health economics and policy
Author: Victor R. Fuchs
Publisher: World Scientific Publishing Company
ISBN: 9789813232860
Category : Business & Economics
Languages : en
Pages : 600
Get Book Here
Book Description
The collection represents an extraordinary intellectual achievement and ... a handbook for anyone thinking about health and health policy.
Author: Ronald Vogel
Publisher: CRC Press
ISBN: 9781439801345
Category : Medical
Languages : en
Pages : 282
Get Book Here
Book Description
Get a comprehensive explanation of the key economic concepts on how the pharmaceutical market functions The pharmaceutical industry has come under intense public scrutiny for the perception of product prices being too high and for concerns about research and development spending. Pharmaceutical Economics and Public Policy carefully explains the fundamentals of pharmaceutical economics while examining spending, costs, rates of return, and policies affecting the industry. This text provides a comprehensive economic analysis of the most important dimensions of the pharmaceutical market with easy-to-understand analysis of the implications of public policy. Key economic concepts necessary for understanding how the pharmaceutical market functions are clearly explained in detail. Though it is a manufacturing industry, the pharmaceutical industry has several economic aspects that make it fundamentally different from any other. Pharmaceutical Economics and Public Policy takes these sometimes confusing and difficult economic aspects within this unique industry and makes them understandable. The book is carefully referenced and includes numerous figures and tables to clearly present data. Topics in Pharmaceutical Economics and Public Policy include: policymaking—self-interest vs. public interest a pharmaceutical market overview empirical data on cost effectiveness of pharmaceutical use the economics and politics of the regulatory process the economics of patent policies pharmaceutical cost structure why price discrimination occurs in patented pharmaceuticals governmental price controls R&D expenditures sales and marketing expenditures rates of profitability in the pharmaceutical industry mergers and acquisitions and the connection to higher risk levels the future of the pharmaceutical industry Pharmaceutical Economics and Public Policy is an invaluable resource for educators, graduate students, policymakers, legislators, policy analysts, government agencies, and trade associations involved with pharmaceuticals.
Author: Thomas Fulda
Publisher: CRC Press
ISBN: 9781439804261
Category : Medical
Languages : en
Pages : 714
Get Book Here
Book Description
Get an invaluable view of the impact of economics and politics on pharmaceuticals in the United States Pharmacy and pharmaceutical drug use are highly regulated and the various regulatory forces interact with diverse goals. Pharmaceutical Public Policy is a comprehensive review of the legislation, trends, business developments, and policy interpretations that have shaped drug use during the last 50 years. This unique single source explains drug regulatory activity, the major insurance and payment systems, and the impact of economics and politics on drug use in the United States. Leading experts provide a thorough and objective look at public policy issues, making this text perfect for upper level undergraduate and graduate level pharmacy, medical, and public health educators and students. Pharmacists and pharmacy students must learn more than just the physical sciences and clinical aspects of the pharmaceutical industry. The rationale for policies, rules, and regulations is integral to understanding how to best serve patients and make the entire pharmaceutical sector more equitable and cost-effective. Pharmaceutical Public Policy examines the most pressing issues facing the industry, including control of the rising costs for drugs and ensuring correct drug usage by patients. This insightful text offers an in depth perspective of the policies and the debates that surround them. Chapters are well-referenced and many include helpful figures and tables to illustrate facts and ideas. Topics in Pharmaceutical Public Policy include: pharmacy law and regulation Medicare and prescription drug coverage FDA drug approval process Medicaid and prescription drugs public health pharmacy Department of Veterans Affairs pharmacy programs Department of Defense pharmacy programs innovative state drug program practices state and federal regulation of pharmacy the future of the pharmaceutical industry managed care pharmacy PBM’s (pharmacy benefit managers) risk minimization importation and reimportation biotechnology and pharmacogenetics policy and issues product promotion competition between drugs drug insurance design patient compliance abuse of prescription drugs health care systems and insurance in Europe much more Pharmaceutical Public Policy is a one-of-a-kind resource that explains just who the players are and the complexity of the issues that are examined in most pharmaceutical policy debates, and is perfect for pharmacy students, educators, other health professionals, trade association leaders, and policymakers.
Author: Mark V. Pauly
Publisher: Elsevier
ISBN: 0444535926
Category : Business & Economics
Languages : en
Pages : 1149
Get Book Here
Book Description
"As a relatively new subdiscipline of economics, health economics has made many contributions to areas of the main discipline, such as insurance economics. This volume provides a survey of the burgeoning literature on the subject of health economics." {source : site de l'éditeur].
Author: Mihajlo Jakovljevic
Publisher: Nova Publishers
ISBN: 9781634847209
Category : Medical
Languages : en
Pages : 190
Get Book Here
Book Description
This book is an attempt to tackle some of the key global health challenges with a focus on the leading, emerging countries and mature free-market economies facing similar issues. It consists of seven chapters written by well-recognized scholars in the field affiliated to academia, pharmaceutical industry and hospital sectors based in Japan, USA, China, Germany, Netherlands, Switzerland, Ireland, Serbia, Bulgaria, Poland and Albania. The contributors had diverse expert profiles in health economics, clinical medicine, public health and population aging. Regional health care issues were processed and referred to the BRICS and N-11 nations, North American region, Far East Asia, Western and Eastern Europe. Some of the difficulties of contemporary health systems tackled in certain chapters were: population aging, health spending, insurance coverage, health technology assessment, costs of pharmaceutical development, neurological disorder and diabetes economics, public health legislation and caregiver assessment in a traditional Asian setting. All of the aforementioned research might give a dynamic impetus and expand a mental horizon to the professionals dealing with these issues. We believe that this book deserves a broad global audience consisting of health care professionals, policy makers, health economists, clinical physicians and lay persons eager to expand their knowledge in the field. Our attitude is based on the worldwide academic recognition of the listed contributors. The degree of success of these ambitiously targeted efforts will be assessed by our esteemed audience in years to come.
